Second, variabilities remained between observed and population-predicted concentrations (Figure 1A), particularly on Day 14 (i.e., steady state), for which data from only 24 patients with CML-CP were available. The gene discussed is CP; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.